通过结合外源性BMAL1表达和多镇压复合体2抑制在人类诱导的多能干细胞中,人工诱导昼夜节律
Hitomi Kaneko1, Taku Kaitsuka2, Kazuhito Tomizawa3
1Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan.
Cellular and molecular life sciences : CMLS
|July 8, 2023
概括
人类诱导的多能干细胞 (iPSCs) 由于表观遗传沉默时钟基因而缺乏昼夜节律. 增强BMAL1和抑制EZH2恢复了这些干细胞中的昼夜基因表达.
科学领域:
- 干细胞生物学 干细胞生物学
- 时间生物学 时间生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 人类诱导的多能干细胞 (iPSC) 对再生医学至关重要,但与体细胞具有功能差异.
- 在iPSC中缺少的一个关键功能是时钟基因的昼夜振荡,这对于正常细胞的时间调节至关重要.
- 在iPSC中缺乏昼夜节律的潜在机制尚未完全理解.
研究的目的:
- 研究人类iPSC中昼夜节律缺失背后的原因.
- 探索基因组甲基化和BMAL1蛋白水平在调节时钟基因表达中的潜在作用.
- 确定恢复iPSCs昼夜功能的策略.
主要方法:
- 生成的人类iPSCs过度表达大脑和肌肉ARNT-like 1 (BMAL1).
- 用GSK126治疗的细胞,GSK126是一种增强剂增强剂的抑制剂,它是基因素甲基转移酶的zest同类物2 (EZH2).
- 监测BMAL1,2期 (PER2) 和其他时钟基因的表达.
主要成果:
- 过度表达BMAL1和抑制EZH2一起诱导iPSCs显著的昼夜节律.
- 观察到内源性BMAL1,PER2和其他关键时钟基因的节奏表达恢复.
- 这些发现表明一种涉及表观遗传调节和BMAL1水平的机制.
结论:
- 人类iPSC中缺乏昼夜节律可能源于通过H3K27高甲基化和低BMAL1水平的时钟基因的转录抑制.
- 调节BMAL1表达和EZH2活性可以恢复iPSCs的昼夜基因振荡.
- 这项研究提供了对iPSC生理学和再生医学潜在治疗点的见解.
更多相关视频
06:53Parallel Measurement of Circadian Clock Gene Expression and Hormone Secretion in Human Primary Cell Cultures
Published on: November 11, 2016
8.4K
10:38Monitoring Cell-autonomous Circadian Clock Rhythms of Gene Expression Using Luciferase Bioluminescence Reporters
Published on: September 27, 2012
22.5K
相关概念视频
Circadian Rhythms and Gene Regulation
4.1K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.1K
Induced Pluripotent Stem Cells
24.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.2K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
